Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SNY
SNY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SNY News
Japan Approves Sarclisa Subcutaneous Injection for Multiple Myeloma
14h ago
NASDAQ.COM
Denali Sells Rare Pediatric Disease Priority Review Voucher for $195 Million
13h ago
NASDAQ.COM
FDA Approves Expanded Use of Sanofi's Diabetes Therapy Tzield
6d ago
seekingalpha
Sanofi's Tzield Receives FDA Accelerated Approval
6d ago
NASDAQ.COM
Dianthus Therapeutics Receives Strong Buy Rating Following Positive Trial Results
Jun 12 2026
stocktwits
Biotech Sector Sees Surge in FDA and Global Approvals
Jun 12 2026
NASDAQ.COM
Sanofi Discontinues Phase 3 Trial for Riliprubart
Jun 10 2026
NASDAQ.COM
Sanofi Halts Phase 3 MOBILIZE Trial of Riliprbutart
Jun 10 2026
seekingalpha
Kymera Therapeutics Secures $20 Million Milestone Payment from Sanofi
Jun 09 2026
Yahoo Finance
EU Approves Sarclisa Subcutaneous Injection for Multiple Myeloma
Jun 08 2026
NASDAQ.COM
Sanofi Launches 2026 Global Employee Shareholder Plan
Jun 04 2026
NASDAQ.COM
Recursion Pharmaceuticals Faces Challenges Despite AI Innovations
May 26 2026
Fool
Recursion Pharmaceuticals Leverages AI to Enhance Drug Development
May 26 2026
NASDAQ.COM
Sanofi: An Underrated Growth Stock
May 18 2026
Fool
Hantavirus Outbreak Sparks Rally in Biotech Stocks
May 13 2026
Fool
Regeneron Secures Accelerated Approval for Gene Therapy Otarmeni
May 08 2026
Fool
Show More News
